Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study

CONCLUSIONS: The efficacy of anaprazole is non-inferior to that of rabeprazole in Chinese patients with duodenal ulcers.REGISTRATION: ClinicalTrials.gov, NCT04215653.PMID:36580650 | DOI:10.1097/CM9.0000000000002508

Source: Chinese Medical Journal - December 29, 2022 Category: General Medicine Authors: Huiyun Zhu Xue Pan Li Zhang Hongxin Sun Huizhen Fan Zhongwei Pan Caibin Huang Zhenwang Shi Jin Ding Qi Wang Yiqi Du Nonghua Lyu Zhaoshen Li Source Type: research